BioNTech Settles mRNA Patent Dispute with GSK and CureVac
BioNTech has reached a settlement in a three-year mRNA patent dispute with GSK and CureVac, a fellow German biotechnology firm. This settlement comes as BioNTech is in the process of…
Breaking News & Top Stories
BioNTech has reached a settlement in a three-year mRNA patent dispute with GSK and CureVac, a fellow German biotechnology firm. This settlement comes as BioNTech is in the process of…